| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.43 | 0.008 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.66 | 0.009 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |